Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global market for Mitral Valve Intervention was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The mitral valve is composed of the mitral valve annulus, mitral valve leaflets, chordae tendineae and papillary muscles. One part of the mitral valve leaflet including the anterior and posterior leaflets is connected to the mitral valve annulus, and the other end is connected to the chordae tendineae, while the chordae tendineae is connected to the mitral valve annulus. It is connected to the papillary muscle and constitutes the structural integrity of the mitral valve. The integrity of mitral valve function requires that the size of the mitral valve annulus is appropriate, the valve leaflet structure is complete, the papillary muscles contract and stretch the chordae tendineae to support the valve leaflets, the left ventricular muscle contraction produces appropriate closing force, and the ventricular morphology and function are normal.
North American market for Mitral Valve Intervention is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mitral Valve Intervention is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Mitral Valve Intervention include Edwards Lifesciences, Abbott, CardioSolution, NeoChord, Mitralign, Medtronic, Boston Scientific, Mitralix, Shanghai Hanyu Medical Technology, Valgen Holding Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mitral Valve Intervention, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mitral Valve Intervention.
The Mitral Valve Intervention market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mitral Valve Intervention market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mitral Valve Intervention manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Report Metric
Details
Report Title
Global Mitral Valve Intervention Market Research Report 2025
Market Size Available for Years
2025-2031
Global Mitral Valve Intervention Companies Covered
Edwards Lifesciences
Abbott
CardioSolution
NeoChord
Mitralign
Medtronic
Boston Scientific
Mitralix
Shanghai Hanyu Medical Technology
Valgen Holding Corporation
NeoChord
CoreMedic
Babic Chord
Gore Medical
Valtech Cardio
Transcardiac
ChoRe
AVVIE
Cardiovalve
HighLife SAS
Neovasc
MitrAssist Lifesciences
Shanghai NewMed Medical
Peijia Medical
MicroPort CardioFlow Medtech
Global Mitral Valve Intervention Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mitral Valve Intervention Market, Segment by Type
Replacement Product
Repair Product
Annulus Products
Global Mitral Valve Intervention Market, Segment by Application
Transapical
Via Stock and Via Interstitial
Right Internal Jugular Vein
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mitral Valve Intervention manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mitral Valve Intervention in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Table of Contents
1 Mitral Valve Intervention Market Overview
1.1 Product Definition
1.2 Mitral Valve Intervention by Type
1.2.1 Global Mitral Valve Intervention Market Value Comparison by Type (2024 VS 2031)
1.2.2 Replacement Product
1.2.3 Repair Product
1.2.4 Annulus Products
1.3 Mitral Valve Intervention by Application
1.3.1 Global Mitral Valve Intervention Market Value by Application (2024 VS 2031)
1.3.2 Transapical
1.3.3 Via Stock and Via Interstitial
1.3.4 Right Internal Jugular Vein
1.4 Global Mitral Valve Intervention Market Size Estimates and Forecasts
1.4.1 Global Mitral Valve Intervention Revenue 2020-2031
1.4.2 Global Mitral Valve Intervention Sales 2020-2031
1.4.3 Global Mitral Valve Intervention Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mitral Valve Intervention Market Competition by Manufacturers
2.1 Global Mitral Valve Intervention Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mitral Valve Intervention Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mitral Valve Intervention Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mitral Valve Intervention, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mitral Valve Intervention, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mitral Valve Intervention, Product Type & Application
2.7 Global Key Manufacturers of Mitral Valve Intervention, Date of Enter into This Industry
2.8 Global Mitral Valve Intervention Market Competitive Situation and Trends
2.8.1 Global Mitral Valve Intervention Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mitral Valve Intervention Players Market Share by Revenue
2.8.3 Global Mitral Valve Intervention Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mitral Valve Intervention Market Scenario by Region
3.1 Global Mitral Valve Intervention Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mitral Valve Intervention Sales by Region: 2020-2031
3.2.1 Global Mitral Valve Intervention Sales by Region: 2020-2025
3.2.2 Global Mitral Valve Intervention Sales by Region: 2026-2031
3.3 Global Mitral Valve Intervention Revenue by Region: 2020-2031
3.3.1 Global Mitral Valve Intervention Revenue by Region: 2020-2025
3.3.2 Global Mitral Valve Intervention Revenue by Region: 2026-2031
3.4 North America Mitral Valve Intervention Market Facts & Figures by Country
3.4.1 North America Mitral Valve Intervention Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mitral Valve Intervention Sales by Country (2020-2031)
3.4.3 North America Mitral Valve Intervention Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mitral Valve Intervention Market Facts & Figures by Country
3.5.1 Europe Mitral Valve Intervention Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mitral Valve Intervention Sales by Country (2020-2031)
3.5.3 Europe Mitral Valve Intervention Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mitral Valve Intervention Market Facts & Figures by Region
3.6.1 Asia Pacific Mitral Valve Intervention Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mitral Valve Intervention Sales by Region (2020-2031)
3.6.3 Asia Pacific Mitral Valve Intervention Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mitral Valve Intervention Market Facts & Figures by Country
3.7.1 Latin America Mitral Valve Intervention Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mitral Valve Intervention Sales by Country (2020-2031)
3.7.3 Latin America Mitral Valve Intervention Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mitral Valve Intervention Market Facts & Figures by Country
3.8.1 Middle East and Africa Mitral Valve Intervention Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mitral Valve Intervention Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mitral Valve Intervention Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Mitral Valve Intervention Sales by Type (2020-2031)
4.1.1 Global Mitral Valve Intervention Sales by Type (2020-2025)
4.1.2 Global Mitral Valve Intervention Sales by Type (2026-2031)
4.1.3 Global Mitral Valve Intervention Sales Market Share by Type (2020-2031)
4.2 Global Mitral Valve Intervention Revenue by Type (2020-2031)
4.2.1 Global Mitral Valve Intervention Revenue by Type (2020-2025)
4.2.2 Global Mitral Valve Intervention Revenue by Type (2026-2031)
4.2.3 Global Mitral Valve Intervention Revenue Market Share by Type (2020-2031)
4.3 Global Mitral Valve Intervention Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mitral Valve Intervention Sales by Application (2020-2031)
5.1.1 Global Mitral Valve Intervention Sales by Application (2020-2025)
5.1.2 Global Mitral Valve Intervention Sales by Application (2026-2031)
5.1.3 Global Mitral Valve Intervention Sales Market Share by Application (2020-2031)
5.2 Global Mitral Valve Intervention Revenue by Application (2020-2031)
5.2.1 Global Mitral Valve Intervention Revenue by Application (2020-2025)
5.2.2 Global Mitral Valve Intervention Revenue by Application (2026-2031)
5.2.3 Global Mitral Valve Intervention Revenue Market Share by Application (2020-2031)
5.3 Global Mitral Valve Intervention Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Edwards Lifesciences
6.1.1 Edwards Lifesciences Company Information
6.1.2 Edwards Lifesciences Description and Business Overview
6.1.3 Edwards Lifesciences Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Edwards Lifesciences Mitral Valve Intervention Product Portfolio
6.1.5 Edwards Lifesciences Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Mitral Valve Intervention Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 CardioSolution
6.3.1 CardioSolution Company Information
6.3.2 CardioSolution Description and Business Overview
6.3.3 CardioSolution Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CardioSolution Mitral Valve Intervention Product Portfolio
6.3.5 CardioSolution Recent Developments/Updates
6.4 NeoChord
6.4.1 NeoChord Company Information
6.4.2 NeoChord Description and Business Overview
6.4.3 NeoChord Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.4.4 NeoChord Mitral Valve Intervention Product Portfolio
6.4.5 NeoChord Recent Developments/Updates
6.5 Mitralign
6.5.1 Mitralign Company Information
6.5.2 Mitralign Description and Business Overview
6.5.3 Mitralign Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mitralign Mitral Valve Intervention Product Portfolio
6.5.5 Mitralign Recent Developments/Updates
6.6 Medtronic
6.6.1 Medtronic Company Information
6.6.2 Medtronic Description and Business Overview
6.6.3 Medtronic Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Medtronic Mitral Valve Intervention Product Portfolio
6.6.5 Medtronic Recent Developments/Updates
6.7 Boston Scientific
6.7.1 Boston Scientific Company Information
6.7.2 Boston Scientific Description and Business Overview
6.7.3 Boston Scientific Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Boston Scientific Mitral Valve Intervention Product Portfolio
6.7.5 Boston Scientific Recent Developments/Updates
6.8 Mitralix
6.8.1 Mitralix Company Information
6.8.2 Mitralix Description and Business Overview
6.8.3 Mitralix Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mitralix Mitral Valve Intervention Product Portfolio
6.8.5 Mitralix Recent Developments/Updates
6.9 Shanghai Hanyu Medical Technology
6.9.1 Shanghai Hanyu Medical Technology Company Information
6.9.2 Shanghai Hanyu Medical Technology Description and Business Overview
6.9.3 Shanghai Hanyu Medical Technology Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shanghai Hanyu Medical Technology Mitral Valve Intervention Product Portfolio
6.9.5 Shanghai Hanyu Medical Technology Recent Developments/Updates
6.10 Valgen Holding Corporation
6.10.1 Valgen Holding Corporation Company Information
6.10.2 Valgen Holding Corporation Description and Business Overview
6.10.3 Valgen Holding Corporation Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Valgen Holding Corporation Mitral Valve Intervention Product Portfolio
6.10.5 Valgen Holding Corporation Recent Developments/Updates
6.11 NeoChord
6.11.1 NeoChord Company Information
6.11.2 NeoChord Description and Business Overview
6.11.3 NeoChord Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.11.4 NeoChord Mitral Valve Intervention Product Portfolio
6.11.5 NeoChord Recent Developments/Updates
6.12 CoreMedic
6.12.1 CoreMedic Company Information
6.12.2 CoreMedic Description and Business Overview
6.12.3 CoreMedic Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CoreMedic Mitral Valve Intervention Product Portfolio
6.12.5 CoreMedic Recent Developments/Updates
6.13 Babic Chord
6.13.1 Babic Chord Company Information
6.13.2 Babic Chord Description and Business Overview
6.13.3 Babic Chord Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Babic Chord Mitral Valve Intervention Product Portfolio
6.13.5 Babic Chord Recent Developments/Updates
6.14 Gore Medical
6.14.1 Gore Medical Company Information
6.14.2 Gore Medical Description and Business Overview
6.14.3 Gore Medical Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Gore Medical Mitral Valve Intervention Product Portfolio
6.14.5 Gore Medical Recent Developments/Updates
6.15 Valtech Cardio
6.15.1 Valtech Cardio Company Information
6.15.2 Valtech Cardio Description and Business Overview
6.15.3 Valtech Cardio Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Valtech Cardio Mitral Valve Intervention Product Portfolio
6.15.5 Valtech Cardio Recent Developments/Updates
6.16 Transcardiac
6.16.1 Transcardiac Company Information
6.16.2 Transcardiac Description and Business Overview
6.16.3 Transcardiac Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Transcardiac Mitral Valve Intervention Product Portfolio
6.16.5 Transcardiac Recent Developments/Updates
6.17 ChoRe
6.17.1 ChoRe Company Information
6.17.2 ChoRe Description and Business Overview
6.17.3 ChoRe Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.17.4 ChoRe Mitral Valve Intervention Product Portfolio
6.17.5 ChoRe Recent Developments/Updates
6.18 AVVIE
6.18.1 AVVIE Company Information
6.18.2 AVVIE Description and Business Overview
6.18.3 AVVIE Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.18.4 AVVIE Mitral Valve Intervention Product Portfolio
6.18.5 AVVIE Recent Developments/Updates
6.19 Cardiovalve
6.19.1 Cardiovalve Company Information
6.19.2 Cardiovalve Description and Business Overview
6.19.3 Cardiovalve Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Cardiovalve Mitral Valve Intervention Product Portfolio
6.19.5 Cardiovalve Recent Developments/Updates
6.20 HighLife SAS
6.20.1 HighLife SAS Company Information
6.20.2 HighLife SAS Description and Business Overview
6.20.3 HighLife SAS Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.20.4 HighLife SAS Mitral Valve Intervention Product Portfolio
6.20.5 HighLife SAS Recent Developments/Updates
6.21 Neovasc
6.21.1 Neovasc Company Information
6.21.2 Neovasc Description and Business Overview
6.21.3 Neovasc Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Neovasc Mitral Valve Intervention Product Portfolio
6.21.5 Neovasc Recent Developments/Updates
6.22 MitrAssist Lifesciences
6.22.1 MitrAssist Lifesciences Company Information
6.22.2 MitrAssist Lifesciences Description and Business Overview
6.22.3 MitrAssist Lifesciences Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.22.4 MitrAssist Lifesciences Mitral Valve Intervention Product Portfolio
6.22.5 MitrAssist Lifesciences Recent Developments/Updates
6.23 Shanghai NewMed Medical
6.23.1 Shanghai NewMed Medical Company Information
6.23.2 Shanghai NewMed Medical Description and Business Overview
6.23.3 Shanghai NewMed Medical Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Shanghai NewMed Medical Mitral Valve Intervention Product Portfolio
6.23.5 Shanghai NewMed Medical Recent Developments/Updates
6.24 Peijia Medical
6.24.1 Peijia Medical Company Information
6.24.2 Peijia Medical Description and Business Overview
6.24.3 Peijia Medical Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Peijia Medical Mitral Valve Intervention Product Portfolio
6.24.5 Peijia Medical Recent Developments/Updates
6.25 MicroPort CardioFlow Medtech
6.25.1 MicroPort CardioFlow Medtech Company Information
6.25.2 MicroPort CardioFlow Medtech Description and Business Overview
6.25.3 MicroPort CardioFlow Medtech Mitral Valve Intervention Sales, Revenue and Gross Margin (2020-2025)
6.25.4 MicroPort CardioFlow Medtech Mitral Valve Intervention Product Portfolio
6.25.5 MicroPort CardioFlow Medtech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mitral Valve Intervention Industry Chain Analysis
7.2 Mitral Valve Intervention Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mitral Valve Intervention Production Mode & Process Analysis
7.4 Mitral Valve Intervention Sales and Marketing
7.4.1 Mitral Valve Intervention Sales Channels
7.4.2 Mitral Valve Intervention Distributors
7.5 Mitral Valve Intervention Customer Analysis
8 Mitral Valve Intervention Market Dynamics
8.1 Mitral Valve Intervention Industry Trends
8.2 Mitral Valve Intervention Market Drivers
8.3 Mitral Valve Intervention Market Challenges
8.4 Mitral Valve Intervention Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Table of Figures
List of Tables
Table 1. Global Mitral Valve Intervention Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Mitral Valve Intervention Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Mitral Valve Intervention Market Competitive Situation by Manufacturers in 2024
Table 4. Global Mitral Valve Intervention Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Mitral Valve Intervention Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Mitral Valve Intervention Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Mitral Valve Intervention Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Mitral Valve Intervention Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Mitral Valve Intervention, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Mitral Valve Intervention, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mitral Valve Intervention, Product Type & Application
Table 12. Global Key Manufacturers of Mitral Valve Intervention, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mitral Valve Intervention by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitral Valve Intervention as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mitral Valve Intervention Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Mitral Valve Intervention Sales by Region (2020-2025) & (K Units)
Table 18. Global Mitral Valve Intervention Sales Market Share by Region (2020-2025)
Table 19. Global Mitral Valve Intervention Sales by Region (2026-2031) & (K Units)
Table 20. Global Mitral Valve Intervention Sales Market Share by Region (2026-2031)
Table 21. Global Mitral Valve Intervention Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Mitral Valve Intervention Revenue Market Share by Region (2020-2025)
Table 23. Global Mitral Valve Intervention Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Mitral Valve Intervention Revenue Market Share by Region (2026-2031)
Table 25. North America Mitral Valve Intervention Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Mitral Valve Intervention Sales by Country (2020-2025) & (K Units)
Table 27. North America Mitral Valve Intervention Sales by Country (2026-2031) & (K Units)
Table 28. North America Mitral Valve Intervention Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Mitral Valve Intervention Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Mitral Valve Intervention Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Mitral Valve Intervention Sales by Country (2020-2025) & (K Units)
Table 32. Europe Mitral Valve Intervention Sales by Country (2026-2031) & (K Units)
Table 33. Europe Mitral Valve Intervention Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Mitral Valve Intervention Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Mitral Valve Intervention Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Mitral Valve Intervention Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Mitral Valve Intervention Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Mitral Valve Intervention Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Mitral Valve Intervention Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Mitral Valve Intervention Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Mitral Valve Intervention Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Mitral Valve Intervention Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Mitral Valve Intervention Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Mitral Valve Intervention Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Mitral Valve Intervention Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Mitral Valve Intervention Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Mitral Valve Intervention Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Mitral Valve Intervention Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Mitral Valve Intervention Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Mitral Valve Intervention Sales (K Units) by Type (2020-2025)
Table 51. Global Mitral Valve Intervention Sales (K Units) by Type (2026-2031)
Table 52. Global Mitral Valve Intervention Sales Market Share by Type (2020-2025)
Table 53. Global Mitral Valve Intervention Sales Market Share by Type (2026-2031)
Table 54. Global Mitral Valve Intervention Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Mitral Valve Intervention Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Mitral Valve Intervention Revenue Market Share by Type (2020-2025)
Table 57. Global Mitral Valve Intervention Revenue Market Share by Type (2026-2031)
Table 58. Global Mitral Valve Intervention Price (US$/Unit) by Type (2020-2025)
Table 59. Global Mitral Valve Intervention Price (US$/Unit) by Type (2026-2031)
Table 60. Global Mitral Valve Intervention Sales (K Units) by Application (2020-2025)
Table 61. Global Mitral Valve Intervention Sales (K Units) by Application (2026-2031)
Table 62. Global Mitral Valve Intervention Sales Market Share by Application (2020-2025)
Table 63. Global Mitral Valve Intervention Sales Market Share by Application (2026-2031)
Table 64. Global Mitral Valve Intervention Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Mitral Valve Intervention Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Mitral Valve Intervention Revenue Market Share by Application (2020-2025)
Table 67. Global Mitral Valve Intervention Revenue Market Share by Application (2026-2031)
Table 68. Global Mitral Valve Intervention Price (US$/Unit) by Application (2020-2025)
Table 69. Global Mitral Valve Intervention Price (US$/Unit) by Application (2026-2031)
Table 70. Edwards Lifesciences Company Information
Table 71. Edwards Lifesciences Description and Business Overview
Table 72. Edwards Lifesciences Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Edwards Lifesciences Mitral Valve Intervention Product
Table 74. Edwards Lifesciences Recent Developments/Updates
Table 75. Abbott Company Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Abbott Mitral Valve Intervention Product
Table 79. Abbott Recent Developments/Updates
Table 80. CardioSolution Company Information
Table 81. CardioSolution Description and Business Overview
Table 82. CardioSolution Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. CardioSolution Mitral Valve Intervention Product
Table 84. CardioSolution Recent Developments/Updates
Table 85. NeoChord Company Information
Table 86. NeoChord Description and Business Overview
Table 87. NeoChord Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. NeoChord Mitral Valve Intervention Product
Table 89. NeoChord Recent Developments/Updates
Table 90. Mitralign Company Information
Table 91. Mitralign Description and Business Overview
Table 92. Mitralign Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Mitralign Mitral Valve Intervention Product
Table 94. Mitralign Recent Developments/Updates
Table 95. Medtronic Company Information
Table 96. Medtronic Description and Business Overview
Table 97. Medtronic Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Medtronic Mitral Valve Intervention Product
Table 99. Medtronic Recent Developments/Updates
Table 100. Boston Scientific Company Information
Table 101. Boston Scientific Description and Business Overview
Table 102. Boston Scientific Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Boston Scientific Mitral Valve Intervention Product
Table 104. Boston Scientific Recent Developments/Updates
Table 105. Mitralix Company Information
Table 106. Mitralix Description and Business Overview
Table 107. Mitralix Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Mitralix Mitral Valve Intervention Product
Table 109. Mitralix Recent Developments/Updates
Table 110. Shanghai Hanyu Medical Technology Company Information
Table 111. Shanghai Hanyu Medical Technology Description and Business Overview
Table 112. Shanghai Hanyu Medical Technology Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Shanghai Hanyu Medical Technology Mitral Valve Intervention Product
Table 114. Shanghai Hanyu Medical Technology Recent Developments/Updates
Table 115. Valgen Holding Corporation Company Information
Table 116. Valgen Holding Corporation Description and Business Overview
Table 117. Valgen Holding Corporation Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Valgen Holding Corporation Mitral Valve Intervention Product
Table 119. Valgen Holding Corporation Recent Developments/Updates
Table 120. NeoChord Company Information
Table 121. NeoChord Description and Business Overview
Table 122. NeoChord Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. NeoChord Mitral Valve Intervention Product
Table 124. NeoChord Recent Developments/Updates
Table 125. CoreMedic Company Information
Table 126. CoreMedic Description and Business Overview
Table 127. CoreMedic Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. CoreMedic Mitral Valve Intervention Product
Table 129. CoreMedic Recent Developments/Updates
Table 130. Babic Chord Company Information
Table 131. Babic Chord Description and Business Overview
Table 132. Babic Chord Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Babic Chord Mitral Valve Intervention Product
Table 134. Babic Chord Recent Developments/Updates
Table 135. Gore Medical Company Information
Table 136. Gore Medical Description and Business Overview
Table 137. Gore Medical Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Gore Medical Mitral Valve Intervention Product
Table 139. Gore Medical Recent Developments/Updates
Table 140. Valtech Cardio Company Information
Table 141. Valtech Cardio Description and Business Overview
Table 142. Valtech Cardio Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Valtech Cardio Mitral Valve Intervention Product
Table 144. Valtech Cardio Recent Developments/Updates
Table 145. Transcardiac Company Information
Table 146. Transcardiac Description and Business Overview
Table 147. Transcardiac Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Transcardiac Mitral Valve Intervention Product
Table 149. Transcardiac Recent Developments/Updates
Table 150. ChoRe Company Information
Table 151. ChoRe Description and Business Overview
Table 152. ChoRe Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. ChoRe Mitral Valve Intervention Product
Table 154. ChoRe Recent Developments/Updates
Table 155. AVVIE Company Information
Table 156. AVVIE Description and Business Overview
Table 157. AVVIE Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. AVVIE Mitral Valve Intervention Product
Table 159. AVVIE Recent Developments/Updates
Table 160. Cardiovalve Company Information
Table 161. Cardiovalve Description and Business Overview
Table 162. Cardiovalve Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Cardiovalve Mitral Valve Intervention Product
Table 164. Cardiovalve Recent Developments/Updates
Table 165. HighLife SAS Company Information
Table 166. HighLife SAS Description and Business Overview
Table 167. HighLife SAS Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. HighLife SAS Mitral Valve Intervention Product
Table 169. HighLife SAS Recent Developments/Updates
Table 170. Neovasc Company Information
Table 171. Neovasc Description and Business Overview
Table 172. Neovasc Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Neovasc Mitral Valve Intervention Product
Table 174. Neovasc Recent Developments/Updates
Table 175. MitrAssist Lifesciences Company Information
Table 176. MitrAssist Lifesciences Description and Business Overview
Table 177. MitrAssist Lifesciences Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. MitrAssist Lifesciences Mitral Valve Intervention Product
Table 179. MitrAssist Lifesciences Recent Developments/Updates
Table 180. Shanghai NewMed Medical Company Information
Table 181. Shanghai NewMed Medical Description and Business Overview
Table 182. Shanghai NewMed Medical Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Shanghai NewMed Medical Mitral Valve Intervention Product
Table 184. Shanghai NewMed Medical Recent Developments/Updates
Table 185. Peijia Medical Company Information
Table 186. Peijia Medical Description and Business Overview
Table 187. Peijia Medical Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. Peijia Medical Mitral Valve Intervention Product
Table 189. Peijia Medical Recent Developments/Updates
Table 190. MicroPort CardioFlow Medtech Company Information
Table 191. MicroPort CardioFlow Medtech Description and Business Overview
Table 192. MicroPort CardioFlow Medtech Mitral Valve Intervention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 193. MicroPort CardioFlow Medtech Mitral Valve Intervention Product
Table 194. MicroPort CardioFlow Medtech Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Mitral Valve Intervention Distributors List
Table 198. Mitral Valve Intervention Customers List
Table 199. Mitral Valve Intervention Market Trends
Table 200. Mitral Valve Intervention Market Drivers
Table 201. Mitral Valve Intervention Market Challenges
Table 202. Mitral Valve Intervention Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mitral Valve Intervention
Figure 2. Global Mitral Valve Intervention Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mitral Valve Intervention Market Share by Type: 2024 & 2031
Figure 4. Replacement Product Product Picture
Figure 5. Repair Product Product Picture
Figure 6. Annulus Products Product Picture
Figure 7. Global Mitral Valve Intervention Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Mitral Valve Intervention Market Share by Application: 2024 & 2031
Figure 9. Transapical
Figure 10. Via Stock and Via Interstitial
Figure 11. Right Internal Jugular Vein
Figure 12. Global Mitral Valve Intervention Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Mitral Valve Intervention Market Size (2020-2031) & (US$ Million)
Figure 14. Global Mitral Valve Intervention Sales (2020-2031) & (K Units)
Figure 15. Global Mitral Valve Intervention Average Price (US$/Unit) & (2020-2031)
Figure 16. Mitral Valve Intervention Report Years Considered
Figure 17. Mitral Valve Intervention Sales Share by Manufacturers in 2024
Figure 18. Global Mitral Valve Intervention Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Mitral Valve Intervention Players: Market Share by Revenue in Mitral Valve Intervention in 2024
Figure 20. Mitral Valve Intervention Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Mitral Valve Intervention Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Mitral Valve Intervention Sales Market Share by Country (2020-2031)
Figure 23. North America Mitral Valve Intervention Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Mitral Valve Intervention Sales Market Share by Country (2020-2031)
Figure 27. Europe Mitral Valve Intervention Revenue Market Share by Country (2020-2031)
Figure 28. Germany Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Mitral Valve Intervention Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Mitral Valve Intervention Revenue Market Share by Region (2020-2031)
Figure 35. China Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Mitral Valve Intervention Sales Market Share by Country (2020-2031)
Figure 46. Latin America Mitral Valve Intervention Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Mitral Valve Intervention Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Mitral Valve Intervention Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Mitral Valve Intervention Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Mitral Valve Intervention by Type (2020-2031)
Figure 56. Global Revenue Market Share of Mitral Valve Intervention by Type (2020-2031)
Figure 57. Global Mitral Valve Intervention Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Mitral Valve Intervention by Application (2020-2031)
Figure 59. Global Revenue Market Share of Mitral Valve Intervention by Application (2020-2031)
Figure 60. Global Mitral Valve Intervention Price (US$/Unit) by Application (2020-2031)
Figure 61. Mitral Valve Intervention Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives InterviewedDescription
The global market for Mitral Valve Intervention was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The mitral valve is composed of the mitral valve annulus, mitral valve leaflets, chordae tendineae and papillary muscles. One part of the mitral valve leaflet including the anterior and posterior leaflets is connected to the mitral valve annulus, and the other end is connected to the chordae tendineae, while the chordae tendineae is connected to the mitral valve annulus. It is connected to the papillary muscle and constitutes the structural integrity of the mitral valve. The integrity of mitral valve function requires that the size of the mitral valve annulus is appropriate, the valve leaflet structure is complete, the papillary muscles contract and stretch the chordae tendineae to support the valve leaflets, the left ventricular muscle contraction produces appropriate closing force, and the ventricular morphology and function are normal.
North American market for Mitral Valve Intervention is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mitral Valve Intervention is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Mitral Valve Intervention include Edwards Lifesciences, Abbott, CardioSolution, NeoChord, Mitralign, Medtronic, Boston Scientific, Mitralix, Shanghai Hanyu Medical Technology, Valgen Holding Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mitral Valve Intervention, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mitral Valve Intervention.
The Mitral Valve Intervention market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mitral Valve Intervention market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mitral Valve Intervention manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mitral Valve Intervention manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mitral Valve Intervention in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Related Reports
The mitral valve is composed of the mitral valve annulus, mitral valve leaflets, chordae tendineae and papillary muscles. One part of the mitral valve leaflet including the anterior and posterior leaflets is connected to the mitral valve annulus, and the other end is connected to the chordae tendineae, while the chordae tendineae is connected to the mitral valve annulus. It is connected to the papillary muscle and constitutes the structural integrity of the mitral valve. The integrity of mitral valve function requires that the size of the mitral valve annulus is appropriate, the valve leaflet structure is complete, the papillary muscles contract and stretch the chordae tendineae to support the valve leaflets, the left ventricular muscle contraction produces appropriate closing force, and the ventricular morphology and function are normal.
Published: 2024-01-17
Pages: 111
USD 2900.00
(Single User License)
The mitral valve is composed of the mitral valve annulus, mitral valve leaflets, chordae tendineae and papillary muscles. One part of the mitral valve leaflet including the anterior and posterior leaflets is connected to the mitral valve annulus, and the other end is connected to the chordae tendineae, while the chordae tendineae is connected to the mitral valve annulus. It is connected to the papillary muscle and constitutes the structural integrity of the mitral valve. The integrity of mitral valve function requires that the size of the mitral valve annulus is appropriate, the valve leaflet structure is complete, the papillary muscles contract and stretch the chordae tendineae to support the valve leaflets, the left ventricular muscle contraction produces appropriate closing force, and the ventricular morphology and function are normal.
Published: 2024-04-12
Pages: 129
USD 4900.00
(Single User License)
The mitral valve is composed of the mitral valve annulus, mitral valve leaflets, chordae tendineae and papillary muscles. One part of the mitral valve leaflet including the anterior and posterior leaflets is connected to the mitral valve annulus, and the other end is connected to the chordae tendineae, while the chordae tendineae is connected to the mitral valve annulus. It is connected to the papillary muscle and constitutes the structural integrity of the mitral valve. The integrity of mitral valve function requires that the size of the mitral valve annulus is appropriate, the valve leaflet structure is complete, the papillary muscles contract and stretch the chordae tendineae to support the valve leaflets, the left ventricular muscle contraction produces appropriate closing force, and the ventricular morphology and function are normal.
Published: 2024-01-10
Pages: 166
USD 3950.00
(Single User License)
The global market for Mitral Valve Intervention was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 156
USD 3950.00
(Single User License)
The global Mitral Valve Intervention market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 188
USD 4900.00
(Single User License)
The global Mitral Valve Intervention market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 114
USD 4250.00
(Single User License)
The global Mitral Valve Intervention market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 143
USD 2900.00
(Single User License)
The global market for Mitral Valve Intervention was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 162
USD 3950.00
(Single User License)
The mitral valve is composed of the mitral valve annulus, mitral valve leaflets, chordae tendineae and papillary muscles. One part of the mitral valve leaflet including the anterior and posterior leaflets is connected to the mitral valve annulus, and the other end is connected to the chordae tendineae, while the chordae tendineae is connected to the mitral valve annulus. It is connected to the papillary muscle and constitutes the structural integrity of the mitral valve. The integrity of mitral valve function requires that the size of the mitral valve annulus is appropriate, the valve leaflet structure is complete, the papillary muscles contract and stretch the chordae tendineae to support the valve leaflets, the left ventricular muscle contraction produces appropriate closing force, and the ventricular morphology and function are normal.
Published: 2024-01-17
Pages: 111
The mitral valve is composed of the mitral valve annulus, mitral valve leaflets, chordae tendineae and papillary muscles. One part of the mitral valve leaflet including the anterior and posterior leaflets is connected to the mitral valve annulus, and the other end is connected to the chordae tendineae, while the chordae tendineae is connected to the mitral valve annulus. It is connected to the papillary muscle and constitutes the structural integrity of the mitral valve. The integrity of mitral valve function requires that the size of the mitral valve annulus is appropriate, the valve leaflet structure is complete, the papillary muscles contract and stretch the chordae tendineae to support the valve leaflets, the left ventricular muscle contraction produces appropriate closing force, and the ventricular morphology and function are normal.
Published: 2024-04-12
Pages: 129
The mitral valve is composed of the mitral valve annulus, mitral valve leaflets, chordae tendineae and papillary muscles. One part of the mitral valve leaflet including the anterior and posterior leaflets is connected to the mitral valve annulus, and the other end is connected to the chordae tendineae, while the chordae tendineae is connected to the mitral valve annulus. It is connected to the papillary muscle and constitutes the structural integrity of the mitral valve. The integrity of mitral valve function requires that the size of the mitral valve annulus is appropriate, the valve leaflet structure is complete, the papillary muscles contract and stretch the chordae tendineae to support the valve leaflets, the left ventricular muscle contraction produces appropriate closing force, and the ventricular morphology and function are normal.
Published: 2024-01-10
Pages: 166
The global market for Mitral Valve Intervention was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 156
The global Mitral Valve Intervention market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 188
The global Mitral Valve Intervention market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 114
The global Mitral Valve Intervention market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 143
The global market for Mitral Valve Intervention was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 162
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database